News

Emmace Achieves Accreditation for ISO 18562-4 Condensate Volume Determination

Emmace Achieves Accreditation for ISO 18562-4 Condensate Volume Determination We are pleased to announce that we have received accreditation from SWEDAC for our internally developed method for determining condensate volume of breathing gas pathways, adhering to ISO 18562-4. This significant achievement underscores Emmace’s dedication to providing cutting-edge biocompatibility testing of medical devices. This accreditation complements […]

Emmace Achieves Accreditation for ISO 18562-4 Condensate Volume Determination Read More »

​Advancing Inhalation Drug Development: iBCS Framework in Focus

Advancing Inhalation Drug Development: iBCS Framework in Focus A new publication co-authored by Per Bäckman, Senior Adviser at Emmace, marks the fourth paper in a series on the Inhalation Biopharmaceutics Classification System (iBCS). Published in Molecular Pharmaceutics, the study explores how iBCS can be applied throughout drug discovery, development, and regulatory evaluation for orally inhaled

​Advancing Inhalation Drug Development: iBCS Framework in Focus Read More »

New Insights into Drug Distribution and Coating in Inhalation Powders​

New Insights into Drug Distribution and Coating in Inhalation Powders A recent study by researchers at RISE and Emmace Consulting (Adj Prof Kyrre Thalberg), published in Surface and Interface Analysis, explores the molecular 3D distribution of budesonide and magnesium stearate (Mg-stearate) in dry powder inhalation formulations. Using advanced ToF-SIMS imaging and XPS analysis, the study reveals

New Insights into Drug Distribution and Coating in Inhalation Powders​ Read More »

Emmace submit a unique and advanced method for ISO accreditation

Emmace Consulting submit a unique and advanced method for ISO accreditation We’re thrilled to announce that our in-house developed method for condensate testing, according to the standard ISO 18562-4:2024 Biocompatibility evaluation of breathing gas pathways in healthcare applications Part 4: Tests for leachables in condensate, has been submitted for ISO 17025 accreditation. Our innovative approach

Emmace submit a unique and advanced method for ISO accreditation Read More »

Leadership Changes to Drive Growth and Innovation

Emmace Announces Leadership Changes to Drive Growth and Innovation Lund, April 15th, 2024 — Emmace Consulting AB, a leading player in the pharmaceutical and medical device sectors, is pleased to announce strategic leadership transitions aimed at strengthening the competitive edge and fueling continued growth. Dr. Anna Holmberg Appointed as New CEO Dr. Anna Holmberg, who has

Leadership Changes to Drive Growth and Innovation Read More »

Kyrre Thalberg

Importance of Mixing Energy on DPI Formulation Properties

Don’t miss learning more about the importance of mixing energy on DPI formulation properties! Spearheaded by Adj. Prof. Kyrre Thalberg, and together with MVIC colleagues, a very insightful study of the effect of mixing energy on the aerodynamic behavior of DPI formulation was conducted in collaboration with Orion Corporation. The publication is open access so

Importance of Mixing Energy on DPI Formulation Properties Read More »

New Year, New Publication!

Let’s kick off the new year with a publication. Adj. Prof. Kyrre Thalberg, Senior Advisor at Emmace Consulting continues sharing science regarding dry powder formulations. Enjoy. The effect of mixing on the dispersibility of adhesive mixtures for inhalation. Comparison of high shear and Turbula mixers.Kyrre Thalberg, Love Ivarsson, Mårten Svensson, Peter Elfman, Ann Ohlsson, Jackie

New Year, New Publication! Read More »

Publication No. 3 from the iBCS Consortium

Publication No. 3 from the iBCS consortium is now published!Emmace Senior Adviser Dr. Per Bäckman is part of an international science group that focuses on Biopharmaceutics Classification System for Orally Inhaled Drug Products (iBCS). Their next publication is now published. iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug ProductsJayne E. Hastedt, Per Bäckman,

Publication No. 3 from the iBCS Consortium Read More »